Athos Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1123 W Carson St, Torrance, California, ...Phone Number
(857) 222-0410Website
www.athostx.comRevenue
$9.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Athos Therapeutics
Athos Therapeutics Inc. is a clinical stage biotechnology company focused on developing artificial intelligence-based Precision Therapeutics for patients suffering from autoimmune diseases, particularly Inflammatory Bowel Disease. The company has created an innovative drug discovery and development platform that integrates medicinal chemistry and systems biology through machine learning to identify and develop novel drugs. Athos aims to harness the power of science and AI to improve human health, targeting key disease factors with safe and efficient compounds. Their mission emphasizes a patient-focused approach, combining technology and objectivity in the pursuit of scientific advancements.Explore more
Athos Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Athos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Athos Therapeutics
Click to see if Athos Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Athos Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Athos Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Athos Therapeutics is spiking on competitors!
Athos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Athos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Athos Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Athos Therapeutics
Compare insights from companies similar to Athos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Athos Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Athos Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Athos Therapeutics.
Athos Therapeutics financials insights
Gather financial insights about Athos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$10.3M
Athos Therapeutics Tech Stack
A closer look at the technologies used by Athos Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Athos Therapeutics News & Media
AI-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr for Secure AI Training in the Cloud
Vultr, the large, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. Powered by NVIDIA HGX H100 systems and running on Dell Technologies’ PowerEdge XE9680 servers, Vultr now offers Athos the needed security and confidentiality for their intellectual property, omics data, and proprietary AI algorithms.AI-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr for Secure AI Training in the Cloud
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Vultr, today announced that Athos Therapeutics, Inc. (“Athos”), has chosen Vultr Cloud GPU to run its AI model training, tuning, and inferenceAthos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063
- ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease - LOS ANGELES, March 29, 2023 /PRNewswire/ -- Athos Therapeutics, Inc. ("Athos"), a clinical stage...Athos Therapeutics Announces Proteomics Research Collaboration for Inflammatory Bowel Disease with Caltech
Athos will use specialized facilities and equipment at Caltech to perform molecular analysis and spectrometry-based proteomics on primary human single cells, blood, and tissue biopsies from de-identified Inflammatory Bowel Disease (IBD) patient samples. LOS ANGELES, Aug. 25, 2022...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Athos Therapeutics
Sign Up For FreeTo access detailed company insights
Athos Therapeutics Inc. is a clinical stage biotechnology company focused on developing artificial intelligence-based Precision Therapeutics for patients suffering from autoimmune diseases, particularly Inflammatory Bowel Disease. The company has created an innovative drug discovery and development platform that integrates medicinal chemistry and s... Read More
